{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,5,19]],"date-time":"2022-05-19T23:11:23Z","timestamp":1653001883131},"reference-count":9,"publisher":"Japanese Urological Association","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Jpn. j. urol"],"published-print":{"date-parts":[[2014]]},"DOI":"10.5980\/jpnjurol.105.134","type":"journal-article","created":{"date-parts":[[2015,8,3]],"date-time":"2015-08-03T22:05:27Z","timestamp":1438639527000},"page":"134-138","source":"Crossref","is-referenced-by-count":0,"title":["SUCCESSFUL COMBINATION CHEMOTHERAPY OF GEMCITABINE PLUS NEDAPLATIN FOR INVASIVE URETERAL SQUAMOUS CELL CARCINOMA"],"prefix":"10.5980","volume":"105","author":[{"given":"Yasutaka","family":"Yamada","sequence":"first","affiliation":[{"name":"Department of Urology, Yokohama Municipal Citizen's Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mitsuru","family":"Kohno","sequence":"additional","affiliation":[{"name":"Department of Urology, Yokohama Municipal Citizen's Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuhiro","family":"Namura","sequence":"additional","affiliation":[{"name":"Department of Urology, Yokohama Municipal Citizen's Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takuto","family":"Sawada","sequence":"additional","affiliation":[{"name":"Department of Urology, Yokohama Municipal Citizen's Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atsushi","family":"Fujikawa","sequence":"additional","affiliation":[{"name":"Department of Urology, Yokohama Municipal Citizen's Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junichi","family":"Ota","sequence":"additional","affiliation":[{"name":"Department of Urology, Yokohama Municipal Citizen's Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masatoshi","family":"Moriyama","sequence":"additional","affiliation":[{"name":"Department of Urology, Yokohama Municipal Citizen's Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"4001","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1) Berz D, Rizack T, Weitzen S, Mega A, Renzulli J and Colvin G: Survival of Patients with Squamous Cell Malignancies of the Upper Urinary Tract. Oncology, 6, 11-18, 2012.","DOI":"10.4137\/CMO.S8103"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2) Loehrer PJ Sr, Einhorn LH and Elson PJ: A randomized comparison of cisplatin alone or in combination with methotrexate, vinblastine, and doxorubicin in patients with metastatic urothelial carcinoma: a cooperative group study. J Clin Oncol., 10, 1066-1073, 1992.","DOI":"10.1200\/JCO.1992.10.7.1066"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3) Von der Maase H, Hansen SW and Roberts JT: Gemcitabine and cisplatin versus methotrexate, vinblastin, doxorubicin, and cisplatin in advanced or metastatic bladder cancer: results of a large, ramdomized, multinational, multicenter, phase III study. J Clin Oncol., 18, 3068-3077, 2000.","DOI":"10.1200\/JCO.2000.18.17.3068"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4) Von der Masse H, Sengelov L and Roberts JT: Long-term survival results of a randomized trial comparing gemcitabine plus cisplatin, with methotrexate, vinblastine, doxorubicin, plus cisplatin in patients with bladder cancer. J Clin Oncol., 23, 4602-4608, 2005.","DOI":"10.1200\/JCO.2005.07.757"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5) Akaza H, Togashi M, Nishio Y, Miki T, Kotake T, Matsuura Y, Yoshida O and Aso Y: PhaseII study of cis-diamminne (glycolato) platinum, 254-S, in patients with advanced germ-cell testicular cancer, prostatic cancer, and transitional-cell carcinoma of the urinary tract. 254-S Urological Cancer Study Group. Cancer Chemother Pharmacol, 31, 187-192, 1992.","DOI":"10.1007\/BF00685546"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6) Kawai Y, Taniuchi S and Okahara S: Relationship between Cisplatin or Nedaplatin-Induced Nephrotoxicity and Renal Accumlation. Biol Pharm Bull., 28, 1385-1388, 2005.","DOI":"10.1248\/bpb.28.1385"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7) Shimada M, Itamochi H and Kigawa J: Nedaplatin: a cisplatin derivative in cancer chemotherapy. Cancer Manage. Res., 5, 67-76, 2013.","DOI":"10.2147\/CMAR.S35785"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8) Ota K: Nedaplatin. Jpn J Cancer Chemoth, 23, 379-387, 1996.","DOI":"10.1038\/379387a0"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9) Shirai T, Hirose T and Noda M: PhaseII study of the combination of gemcitabine and nedaplatin for advanced non-small-cell lung cancer. Lung Cancer., 52, 181-187, 2006.","DOI":"10.1016\/j.lungcan.2006.01.004"}],"container-title":["The Japanese Journal of Urology"],"original-title":["gemcitabine, nedaplatin\u4f75\u7528\u5316\u5b66\u7642\u6cd5\u304c\u6709\u7528\u3067\u3042\u3063\u305f\u6d78\u6f64\u6027\u5c3f\u7ba1\u6241\u5e73\u4e0a\u76ae\u764c\u306e1\u4f8b"],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jpnjurol\/105\/3\/105_134\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,19]],"date-time":"2022-05-19T22:32:57Z","timestamp":1652999577000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jpnjurol\/105\/3\/105_134\/_article\/-char\/ja\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014]]},"references-count":9,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2014]]}},"URL":"https:\/\/doi.org\/10.5980\/jpnjurol.105.134","relation":{},"ISSN":["0021-5287","1884-7110"],"issn-type":[{"value":"0021-5287","type":"print"},{"value":"1884-7110","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014]]}}}